comparemela.com

Page 6 - Inopharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Health News Roundup: New bird flu cases identified in Pennsylvania and Utah, USDA says; Shanghai targets lockdown turning point by Wednesday - sources and more

Following is a summary of current health news briefs. More Chinese cities tighten controls as Shanghai COVID cases rise Shanghai reported a record number of symptomatic COVID-19 cases on Saturday and other areas across China tightened controls as the country kept up its "dynamic clearance" approach that aims to stamp out the highly transmissible Omicron variant.

2nd booster shot to reinforce immunity: Palace

(File photo) MANILA - The government's plan to start providing second Covid-19 vaccine booster shots for some sectors is part of the efforts to strengthen the immune defenses of Filipinos amid the Covid-19 pandemic, Malacanang said Monday. Acting presidential spokesperson and Communications Secretary Martin Andanar made this remark after the Department of Health (DOH) announced its planned rollout this week of the second Covid-19 booster shot for an initial batch of 1.8 million healthcare workers, elderly and immunocompromised patients. "The second booster dose recently approved by the Food and Drug Administration (FDA) and being planned for by the National Covid-19 Vaccination Operations Center is our scientific response to waning immunity," Andanar said in a press statement. He said a second Covid-19 vaccine booster should be given because it helps people maintain strong protection from severe Covid-19 and death. "Our goal is to reinforce the shield that will prote

COVID-19: Omicron-specific Sinopharm, Sinovac vaccine candidates cleared for clinical trial in Hong Kong

The two candidates from units of Sinopharm subsidiary China National Biotec Group (CNBG) and one from Sinovac contain inactivated or "killed" coronavirus.

Sinopharm testing Omicron vaccine

BEIJING: The Chinese drugmaker Sinopharm says a subsidiary has received approval for clinical trials of a new vaccine specifically to target the Omicron coronavirus variant.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.